Showing results (61-70 of 155) with videos related to
Sort By:
Pageof 16
JTO Clinical and Research Reports|September 30, 2021
Development and Validation of a Simplified Prognostic Score in SCLCElodie Negre, Amandine Coffy, Alexandra Langlais, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 3, 2010
Osteoblastic reaction in non-small cell lung carcinoma and its association to epidermal growth factor receptor tyrosine kinase inhibitors response and prolonged survivalEmilie Pluquet, Jacques Cadranel, Anne Legendre, et al.Lung Cancer (Amsterdam, Netherlands)|January 22, 2016
Non-small cell lung cancer patients with brain metastases treated with first-line platinum-doublet chemotherapy: Analysis from the European FRAME studyDenis Moro-Sibilot, Egbert Smit, Javier de Castro Carpeño, et al.Lung Cancer (Amsterdam, Netherlands)|January 7, 2014
Immunohistochemistry evaluation of biomarker expression in non-small cell lung cancer (Pharmacogenoscan study)Anne-Claire Toffart, Jean-François Timsit, Sébastien Couraud, et al.Journal of the National Cancer Institute|April 7, 2005
Randomized study of maintenance vinorelbine in responders with advanced non-small-cell lung cancerVirginie Westeel, Elisabeth Quoix, Denis Moro-Sibilot, et al.Lung Cancer (Amsterdam, Netherlands)|June 11, 2015
Non-small cell lung cancer recurrence following surgery and perioperative chemotherapy: Comparison of two chemotherapy regimens (IFCT-0702: A randomized phase 3 final results study)Denis Moro-Sibilot, Clarisse Audigier-Valette, Patrick Merle, et al.Lung Cancer (Amsterdam, Netherlands)|April 20, 2010
Randomized phase II trial of gefitinib or gemcitabine or docetaxel chemotherapy in patients with advanced non-small-cell lung cancer and a performance status of 2 or 3 (IFCT-0301 study)Jean-François Morère, Jeanne-Marie Bréchot, Virginie Westeel, et al.Lung Cancer (Amsterdam, Netherlands)|February 20, 2022
Detection of acquired TERT amplification in addition to predisposing p53 and Rb pathways alterations in EGFR-mutant lung adenocarcinomas transformed into small-cell lung cancersAnne Mc Leer, Matthieu Foll, Marie Brevet, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 16, 2018
A Brief Report of Transformation From NSCLC to SCLC: Molecular and Therapeutic CharacteristicsLéonie Ferrer, Matteo Giaj Levra, Marie Brevet, et al.BMC Cancer|December 22, 2014
Evaluation of RECIST in chemotherapy-treated lung cancer: the Pharmacogenoscan StudyAnne-Claire Toffart, Denis Moro-Sibilot, Sébastien Couraud, et al.Pageof 16